Home > News > Neurim Pharmaceuticals licenses Circadin®, a drug approved for the treatment of primary insomnia, to Lundbeck
Dr. Zach Pearl
Circadin.com Staff
Sign up to our newsletter and we will keep you updated with interesting articles about sleep and sleep disorders:
I'm a Healthcare Professional
Accept Terms & Conditions.